These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1689611)

  • 1. Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer.
    Mace KF; Hornung RL; Wiltrout RH; Young HA
    Cancer Res; 1990 Mar; 50(6):1742-7. PubMed ID: 1689611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer.
    Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH
    Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes.
    Futami H; Eader LA; Komschlies KL; Bull R; Gruys ME; Ortaldo JR; Young HA; Wiltrout RH
    Cancer Res; 1991 Dec; 51(24):6596-602. PubMed ID: 1742732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
    J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of multiple cytokine gene expression and IRF-1 mRNA by flavone acetic acid in a murine macrophage cell line.
    Eader LA; Gusella L; Dorman L; Young HA
    Cell Immunol; 1994 Aug; 157(1):211-22. PubMed ID: 8039245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
    Ching LM; Joseph WR; Crosier KE; Baguley BC
    Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.
    Wiltrout RH; Boyd MR; Back TC; Salup RR; Arthur JA; Hornung RL
    J Immunol; 1988 May; 140(9):3261-5. PubMed ID: 3258894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
    Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Cao Z; Baguley BC; Ching LM
    Cancer Res; 2001 Feb; 61(4):1517-21. PubMed ID: 11245459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytokine gene expression in mice after repeated and subchronic oral exposure to vomitoxin (Deoxynivalenol): differential toxin-induced hyporesponsiveness and recovery.
    Zhou HR; Yan D; Pestka JJ
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):347-58. PubMed ID: 9707511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of IFN-gamma and tumor necrosis factor-alpha expression in vivo. Effects of cycloheximide and cyclosporine in normal and lipopolysaccharide-treated mice.
    Cockfield SM; Ramassar V; Halloran PF
    J Immunol; 1993 Jan; 150(2):342-52. PubMed ID: 8419467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
    Drescher KM; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
    Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
    Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course.
    Zhou HR; Yan D; Pestka JJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):294-305. PubMed ID: 9194413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.
    Eisenthal A; Cameron RB; Rosenberg SA
    J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.
    Deng W; Thiel B; Tannenbaum CS; Hamilton TA; Stuehr DJ
    J Immunol; 1993 Jul; 151(1):322-9. PubMed ID: 7686939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.